Grow your business safely with ERYTECH PHARMA
All the information you need about ERYTECH PHARMA to develop and secure your business in France
E
HOME >
CORPORATES
>
ERYTECH PHARMA >
BALANCE SHEET (
2021-07-30)
THE LIST OF BALANCE SHEET : ERYTECH PHARMA
| Deposit | Confidentiality | closing date | document |
|---|---|---|---|
| 2022-07-13 | Public | 2021-12-31 | Complete |
| 2021-07-30 | Public | 2020-12-31 | Consolidated |
| 2021-07-28 | Public | 2020-12-31 | Complete |
| 2020-08-17 | Public | 2019-12-31 | Consolidated |
| 2020-08-07 | Public | 2019-12-31 | Complete |
| 2019-09-16 | Public | 2018-12-31 | Consolidated |
| 2018-07-18 | Public | 2017-12-31 | Complete |
| 2017-07-27 | Public | 2016-12-31 | Complete |
| Name | ERYTECH PHARMA |
| Siren | 479560013 |
| Closing | 2020-12-31 |
| Registry code | 6901 |
| Registration number | B2021/027795 |
| Management number | 2004B04649 |
| Activity code | 7211Z |
| Closing date n-1 | 2019-12-31 |
| Duration Fiscal year | 12 |
| Duration Fiscal year n-1 | 12 |
| Filing date | 2021-07-30 |
| Modification | 00 Annual accounts entered without anomaly |
| Balance sheet type | K : Consolidated |
| Currency code | EUR |
| Confidentiality | Public |
| Address | 69008 LYON |
| 1 - Assets (balance sheet) | Gross amount N | Amortization year N | Net year N | Net year N-1 |
AJ Other Intangible Assets | 589 000.00 | |||
AT Other tangible assets | 20 862 000.00 | |||
BH Other financial assets | 9 319 000.00 | |||
BJ TOTAL (I) | 30 770 000.00 | |||
BN Goods in progress | 8 000.00 | |||
BX Customers and related accounts | 4 000.00 | |||
BZ Other receivables | 5 182 000.00 | |||
CF Cash and cash equivalents | 44 446 000.00 | |||
CJ TOTAL (II) | 49 632 000.00 | |||
CO Grand total (0 to V) | 80 402 000.00 | |||
| 2 - Liabilities (balance sheet) | Amount year N | Amount year N-1 | ||
DA Share or individual capital | 2 006 000.00 | 1 794 000.00 | 2 006 000.00 | |
DB Share, merger, contribution premiums, etc. | 120 705 000.00 | 281 688 000.00 | 120 705 000.00 | |
DD Legal reserve (1) | -24 616 000.00 | -136 607 000.00 | -24 616 000.00 | |
DL TOTAL (I) | 26 539 000.00 | 85 560 000.00 | 26 539 000.00 | |
DP Provisions for Risks | 652 000.00 | 577 000.00 | 652 000.00 | |
DR TOTAL (IV) | 652 000.00 | 577 000.00 | 652 000.00 | |
DV Miscellaneous Loans and Financial Debts (4) | 16 644 000.00 | 14 123 000.00 | 16 644 000.00 | |
DX Trade payables and related accounts | 20 910 000.00 | 13 775 000.00 | 20 910 000.00 | |
EA Other liabilities | 15 657 000.00 | 4 510 000.00 | 15 657 000.00 | |
EC TOTAL (IV) | 53 211 000.00 | 32 408 000.00 | 53 211 000.00 | |
EE Grand total (I to V) | 80 402 000.00 | 118 545 000.00 | 80 402 000.00 | |
P1 LIABILITIES - Equity | 1 744 000.00 | 1 344 000.00 | 1 744 000.00 | |
P2 LIABILITIES - Gross Technical Reserves | -73 300 000.00 | -62 659 000.00 | -73 300 000.00 | |
| 3 - Income statement | Amount France year N | Amount Export year N | Total year N | Total year N-1 |
FQ Other income | 3 718 000.00 | |||
FR Total operating income (I) | 3 718 000.00 | |||
GE Other Expenses | 72 550 000.00 | |||
GF Total Operating Expenses (II) | 72 550 000.00 | |||
GG - OPERATING RESULT (I - II) | -68 832 000.00 | |||
GO Net income from sales of marketable securities | 889 000.00 | |||
GP Total financial income (V) | 889 000.00 | |||
GT Net expenses on sales of marketable securities | 5 354 000.00 | |||
GU Total financial expenses (VI) | 5 354 000.00 | |||
GV - FINANCIAL INCOME (V - VI) | -4 465 000.00 | |||
GW - CURRENT INCOME BEFORE TAX (I - II + III - IV + V - VI) | -73 297 000.00 | |||
| 4 - Income statement (continued) | Amount year N | Amount year N-1 | ||
HK Income tax | -3 000.00 | 1 000.00 | -3 000.00 | |
R6 Group Income (Consolidated Net Income) | -73 300 000.00 | -62 659 000.00 | -73 300 000.00 | |
all companies in France
Complete and comprehensive database.
